Neurocrine Bioscience buy Deutsche Bank Aktiengesellschaft
Start price
12.12.23
/
50%
€111.60
Target price
12.12.24
€126.18
Performance (%)
7.89%
End price
13.12.24
€120.40
Summary
This prediction ended on 13.12.24 with a price of €120.40. With a performance of 7.89%, the BUY prediction by Deutsche_Bank_Aktien for Neurocrine Bioscience closed with a slight gain. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% | 7.429% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Deutsche_Bank_Aktien gewählte maximale Laufzeit wurde überschritten